The European/Australasian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT) Study Group. Oral anticoagulation in patients after cerebral ischemia of arterial origin and risk of intracranial hemorrhage.

Translated title of the contribution: The European/Australasian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT) Study Group. Oral anticoagulation in patients after cerebral ischemia of arterial origin and risk of intracranial hemorrhage.
  • A. Algra

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contributionThe European/Australasian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT) Study Group. Oral anticoagulation in patients after cerebral ischemia of arterial origin and risk of intracranial hemorrhage.
Original languageUndefined/Unknown
Pages (from-to)e45-e47
Number of pages3
JournalStroke
Volume34
Publication statusPublished - 2003

Cite this